Antithrombin regulates neutrophil activities through the stimulation of C-type lectin family 1A

Yohei Takahashi , Soe Soe Htwe , Dengli Wang , Hidenori Wake , Mariko Yata , Nahoko Tomonobu , Rie Kinoshita , Masakiyo Sakaguchi , Masahiro Nishibori
{"title":"Antithrombin regulates neutrophil activities through the stimulation of C-type lectin family 1A","authors":"Yohei Takahashi ,&nbsp;Soe Soe Htwe ,&nbsp;Dengli Wang ,&nbsp;Hidenori Wake ,&nbsp;Mariko Yata ,&nbsp;Nahoko Tomonobu ,&nbsp;Rie Kinoshita ,&nbsp;Masakiyo Sakaguchi ,&nbsp;Masahiro Nishibori","doi":"10.1016/j.bvth.2024.100032","DOIUrl":null,"url":null,"abstract":"<div><h3>Abstract</h3><div>It has been suggested that a serine proteinase inhibitor, antithrombin (AT), exerts anti-inflammatory effects on different types of cells, independent of thrombin inhibition. In this study, we aimed to identify a specific receptor for AT by a screening method using a transmembrane–tethered AT ligand expressed on HEK293T cells together with the coexpression of candidate receptors, followed by the immunoprecipitation of a complex of AT ligand with a receptor. We identified C-type lectin family 1A (CLEC1A) as a receptor for AT. We confirmed the binding of AT to the extracellular domain of CLEC1A using surface plasmon resonance. Recombinant as well as native AT concentration-dependently induced the rounding of purified human neutrophils in shape, associated with the suppression of spontaneous reactive oxygen species production in vitro, but argatroban did not, indicating the independence of AT effects on thrombin inhibition. Native AT maintained the passage of neutrophils through the artificial microcapillaries. Both AT enhanced the phagocytosis of pHrodo-labeled <em>Escherichia coli</em> and prolonged the viability of the neutrophils. The cellular effects of AT were similar to those of histidine-rich glycoprotein, which has the same CLEC1A as a receptor, and were partially inhibited by the addition of anti-CLEC1A antibody to the incubation media. These results suggested that CLEC1A is a novel receptor for AT, and the stimulation of CLEC1A by AT at least in part mediates the important functional changes of human neutrophils.</div></div>","PeriodicalId":100190,"journal":{"name":"Blood Vessels, Thrombosis & Hemostasis","volume":"2 1","pages":"Article 100032"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Vessels, Thrombosis & Hemostasis","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950327224000329","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

It has been suggested that a serine proteinase inhibitor, antithrombin (AT), exerts anti-inflammatory effects on different types of cells, independent of thrombin inhibition. In this study, we aimed to identify a specific receptor for AT by a screening method using a transmembrane–tethered AT ligand expressed on HEK293T cells together with the coexpression of candidate receptors, followed by the immunoprecipitation of a complex of AT ligand with a receptor. We identified C-type lectin family 1A (CLEC1A) as a receptor for AT. We confirmed the binding of AT to the extracellular domain of CLEC1A using surface plasmon resonance. Recombinant as well as native AT concentration-dependently induced the rounding of purified human neutrophils in shape, associated with the suppression of spontaneous reactive oxygen species production in vitro, but argatroban did not, indicating the independence of AT effects on thrombin inhibition. Native AT maintained the passage of neutrophils through the artificial microcapillaries. Both AT enhanced the phagocytosis of pHrodo-labeled Escherichia coli and prolonged the viability of the neutrophils. The cellular effects of AT were similar to those of histidine-rich glycoprotein, which has the same CLEC1A as a receptor, and were partially inhibited by the addition of anti-CLEC1A antibody to the incubation media. These results suggested that CLEC1A is a novel receptor for AT, and the stimulation of CLEC1A by AT at least in part mediates the important functional changes of human neutrophils.
抗凝血酶通过刺激c型凝集素家族1A调节中性粒细胞活性
已有研究表明,丝氨酸蛋白酶抑制剂抗凝血酶(AT)对不同类型的细胞具有抗炎作用,不依赖于凝血酶的抑制。在这项研究中,我们的目的是通过筛选方法,利用在HEK293T细胞上表达的跨膜系留AT配体和候选受体的共表达,然后免疫沉淀AT配体与受体的复合物,来鉴定特异性的AT受体。我们发现c型凝集素家族1A (CLEC1A)是AT的受体。我们利用表面等离子体共振证实了AT与CLEC1A细胞外结构域的结合。重组和天然AT浓度依赖性地诱导纯化的人中性粒细胞形状圆圆,与体外自发活性氧产生的抑制有关,但阿加曲班没有,表明AT对凝血酶抑制的独立性。天然AT维持中性粒细胞通过人工微血管的通道。两种药物均能增强phrodo标记的大肠杆菌的吞噬能力,延长中性粒细胞的活力。AT的细胞效应与富组氨酸糖蛋白相似,后者具有相同的CLEC1A受体,在培养培养基中加入抗CLEC1A抗体可部分抑制AT的细胞效应。这些结果表明,CLEC1A是一种新的AT受体,AT对CLEC1A的刺激至少在一定程度上介导了人中性粒细胞的重要功能变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信